27 min listen
Immunotherapy to Treat Metastatic HER2-Positive Breast Cancer: ESMO 2019 Coverage
Immunotherapy to Treat Metastatic HER2-Positive Breast Cancer: ESMO 2019 Coverage
ratings:
Length:
10 minutes
Released:
Oct 14, 2019
Format:
Podcast episode
Description
Dr. Leisha Emens is professor of medicine in hematology/oncology at the University of Pittsburgh Hillman Cancer Center. She is also co-leader of the Hillman Cancer Immunology and Immunotherapy Program and director of translational immunotherapy for the Women’s Cancer Research Center. She is internationally recognized for her work in breast cancer immunotherapy.
At the European Society for Medical Oncology 2019 Congress, she presented overall survival results from the KATE2 study, which compared using the combination of Tecentriq, also called atezolizumab, and Kadcyla, also called T-DM1, to Kadcyla alone to treat HER2-positive metastatic breast cancer that had grown while being treated with Herceptin and chemotherapy.
Listen to the podcast to hear Dr. Emens discuss:
the design of the KATE2 study
why the study is encouraging, even though it didn't meet its primary endpoint
what the results mean for people diagnosed with HER2-positive metastatic breast cancer
her advice to people diagnosed with breast cancer who are interested in immunotherapy
At the European Society for Medical Oncology 2019 Congress, she presented overall survival results from the KATE2 study, which compared using the combination of Tecentriq, also called atezolizumab, and Kadcyla, also called T-DM1, to Kadcyla alone to treat HER2-positive metastatic breast cancer that had grown while being treated with Herceptin and chemotherapy.
Listen to the podcast to hear Dr. Emens discuss:
the design of the KATE2 study
why the study is encouraging, even though it didn't meet its primary endpoint
what the results mean for people diagnosed with HER2-positive metastatic breast cancer
her advice to people diagnosed with breast cancer who are interested in immunotherapy
Released:
Oct 14, 2019
Format:
Podcast episode
Titles in the series (100)
Research Highlights From the San Antonio Breast Cancer Symposium, December 12, 2013: Our experts discuss the latest research out of SABCS 2013 by Breastcancer.org Podcast